collectionsCollection
Endpoints News
Endpoints News is the fastest read on what biotech and pharma are doing in oncology, deal by deal.
Endpoints sends daily newsletters and is strong on China-out licensing and ADC/bispecific deal flow.
Holds
Biopharma industry news: deals, readouts, regulatory decisions, executive moves.
Licence
Freemium; premium subscription
Maintainer
Endpoints News
Nothing links here yet.